Precision Optics Corporation, Inc. (POCI) - 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for the period ended March 31, 2026. Precision Optics Corporation, Inc. is a developer and manufacturer of advanced optical instruments, primarily serving the medical device and defense/aerospace sectors. The company operates through four business areas: systems manufacturing, engineering and product development, Ross Optical components, and a micro-optics laboratory.
Key Financial Metrics
| Metric | Three Months Ended Mar 31, 2026 | Nine Months Ended Mar 31, 2026 |
|---|---|---|
| Revenues | $8,708,631 | $22,757,291 |
| Gross Profit | $2,056,534 | $3,207,552 |
| Gross Margin | 23.6% | 14.1% |
| Operating Income (Loss) | $(64,462) | $(3,402,046) |
| Net Income (Loss) | $(108,283) | $(3,526,104) |
| Cash and Cash Equivalents | $10,680,046 (End of Period) | $10,680,046 (End of Period) |
| Total Debt (Current + Long-Term) | $1,433,678 | $1,433,678 |
Note: Debt figures include current maturities of long-term debt ($577,898) and long-term debt net of current maturities ($855,780).
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 108.0% for the quarter and 76.3% for the nine-month period compared to the prior year. This was driven primarily by a 206.4% increase in Systems Manufacturing revenue.
- Profitability: The company significantly reduced its net loss. The quarterly loss narrowed from $(2,096,761) in the prior year to $(108,283). The nine-month loss decreased from $(4,377,689) to $(3,526,104).
- Liquidity: Cash and cash equivalents surged from $1,773,735 at June 30, 2025, to $10,680,046 at March 31, 2026. This increase was primarily due to a public offering of common stock in March 2026, which generated net proceeds of $10,630,678.
- Segment Performance: While Systems Manufacturing and Ross Optical Industries saw significant growth, the MicroOptics Lab revenue declined 72.4% due to delays in defense customer orders.
Guidance, Outlook, and Risks
- Debt Covenant Compliance: The company is currently not in compliance with its minimum Debt Service Coverage ratio covenant (1.20x) as of March 31, 2026. Management does not expect to meet this covenant for fiscal 2026 and is in discussions with the lender for a waiver. However, the company states it has sufficient liquidity to repay loans if demanded.
- Capital Expenditures: The company has open purchase orders totaling approximately $6,200,000.
- Government Grants: The company recognized $224,544 in grant income during the quarter, recorded as a reduction to Cost of Goods Sold.
- Outlook: Management believes available cash and capital market access will be sufficient for working capital and capital expenditure requirements for at least 12 months.
Investor Verification Checklist
- Debt Covenant Status: Verify the outcome of discussions with Main Street Bank regarding the waiver of the Debt Service Coverage ratio covenant.
- MicroOptics Lab Recovery: Monitor the status of delayed defense orders impacting the MicroOptics Lab segment.
- Use of Proceeds: Track the deployment of the $10.6 million raised in the March 2026 public offering against the $6.2 million in open purchase orders and working capital needs.
- Margin Sustainability: Assess whether the improved gross margin in Systems Manufacturing (driven by volume and grants) is sustainable without the one-time grant income.